Literature DB >> 3378383

The use of serum methadone levels in patients receiving methadone maintenance.

J Bell1, V Seres, P Bowron, J Lewis, R Batey.   

Abstract

Trough serum methadone concentration was measured in 43 patients under treatment for heroin addiction and complaining of withdrawal symptoms. Low serum levels were noted only in patients taking very low doses and in 10 patients who were concomitantly using enzyme-inducing drugs. The 27 patients in the maintenance program who had trough levels greater than 100 ng/ml were given no dose increase and were followed up prospectively. Alternate explanations for the patient's symptoms were well accepted in almost all cases, and subsequent performance in the treatment program appeared to be independent of serum level. We conclude that a trough serum level of 100 ng/ml is adequate for effective methadone maintenance. Measurement of serum levels can be a valuable intervention in patients with difficulties.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3378383     DOI: 10.1038/clpt.1988.86

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  12 in total

1.  Psychophysiological reactions in methadone maintenance patients do not correlate with methadone plasma levels.

Authors:  N Loimer; R Schmid; J Grünberger; R Jagsch; L Linzmayer; O Presslich
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 2.  Safety considerations in the use of drug combinations during general anaesthesia.

Authors:  E S Ransom; R A Mueller
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

Review 3.  Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Authors:  Chin B Eap; Thierry Buclin; Pierre Baumann
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Pharmacogenetics of Methadone Response.

Authors:  Francina Fonseca; Marta Torrens
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

5.  Steady-state pharmacokinetics of methadone in opioid addicts.

Authors:  K Wolff; A W Hay; D Raistrick; R Calvert
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  Opiate-dependent patients receiving methadone. How physicians should manage therapy.

Authors:  M Kahan; N Sutton
Journal:  Can Fam Physician       Date:  1996-09       Impact factor: 3.275

Review 7.  Drug interactions of clinical significance with opioid analgesics.

Authors:  P M Maurer; R R Bartkowski
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

Review 8.  Methadone maintenance treatment: an update.

Authors:  G Bertschy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

9.  Treatment of polydrug-using opiate dependents during withdrawal: towards a standardisation of treatment.

Authors:  Øistein Kristensen; Terje Lølandsmo; Ase Isaksen; John-Kåre Vederhus; Thomas Clausen
Journal:  BMC Psychiatry       Date:  2006-11-15       Impact factor: 3.630

10.  In silico ordinary differential equation/partial differential equation hemodialysis model estimates methadone removal during dialysis.

Authors:  Oscar A Linares; William E Schiesser; Jeffrey Fudin; Thien C Pham; Jeffrey J Bettinger; Roy O Mathew; Annemarie L Daly
Journal:  J Pain Res       Date:  2015-07-22       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.